ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,397,028, issued on Aug. 26, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).
"Adoptive cellular therapy" was invented by James Brian Rottman (Sudbury, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides improved compositions and methods for the treatment of solid cancers."
The patent was filed on June 5, 2024, under Application No. 18/734,010.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12397028&OS=12397028&RS=12397028
Disclaimer: Curated b...